Patent · US Active

Functional and hyperfunctional siRNA

US7691997B2 · kind B2 · utility

220Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2005
Grant dateApr 6, 2010
Priority date
Expiry dateJul 23, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.